The road to recovery: a pilot study of driving behaviors following antibody-mediated encephalitis - Day GS, Babulal GM, Rajasekar G, Stout S, Roe CM.
INTRODUCTION: Safe driving requires integration of higher-order cognitive and motor functions, which are commonly compromised in patients with antibody-mediated encephalitis (AME) associated with N-methyl-D-aspartate receptors or leucine-rich glioma-inacti... (Source: SafetyLit)
Source: SafetyLit - August 31, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas in NRG Oncology clinical trial
(NRG Oncology) A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2020 Category: Cancer & Oncology Source Type: news

FEFU scientists are developing genetic methods to understand malignant tumors
(Far Eastern Federal University) Scientists of Far Eastern Federal University (FEFU University) get started studying the formation and survival mechanisms of the brain malignant tumors cells, i.e. glioma, to reveal new ways for diagnosis and therapy for this fatal disease. This research was supported by the grant from Russian Science Foundation (RSF). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2020 Category: Cancer & Oncology Source Type: news

Drugs against alpha-ketoglutarate may combat deadly childhood brain tumor
(NIH/National Institute of Neurological Disorders and Stroke) Every year, 150 to 300 children in the United States are diagnosed with diffuse intrinsic pontine gliomas (DIPGs), aggressive and lethal tumors that grow deep inside the brain, for which there are no cures. In a study funded by the National Institutes of Health, researchers showed that experimental drugs designed to lower the body's natural production of alpha-ketoglutarate extended the lives of mice harboring DIPG tumors by slowing the growth of the cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 18, 2020 Category: Cancer & Oncology Source Type: news

The structural basis of Focal Adhesion Kinase activation on lipid membranes unravelled
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) * Patients with glioma - a very common type of tumour originating in the brain - see improvement in survival rates with combined treatment of radiotherapy plus temozolomide* Researchers found a novel mechanism on how tumours evade chemotherapy through genomic rearrangements of the MGMT DNA repair gene* This finding is potentially relevant for updating the methods used to monitor temozolomide efficacy. Genomic rearrangement could be a marker to be detected in blood samples and help make therapeutic decisions (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2020 Category: Cancer & Oncology Source Type: news

A research team of the CNIO and the HKUST identifies how some gliomas develop chemoresistance
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) * Patients with glioma - a very common type of tumour originating in the brain - see improvement in survival rates with combined treatment of radiotherapy plus temozolomide* Researchers found a novel mechanism on how tumours evade chemotherapy through genomic rearrangements of the MGMT DNA repair gene* This finding is potentially relevant for updating the methods used to monitor temozolomide efficacy. Genomic rearrangement could be a marker to be detected in blood samples and help make therapeutic decisions (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 4, 2020 Category: Cancer & Oncology Source Type: news

New treatment strategy may benefit patients with brain cancer
(Massachusetts General Hospital) A team led by investigators at Massachusetts General Hospital has uncovered a potentially promising strategy to treat gliomas with mutations in the IDH genes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2020 Category: Cancer & Oncology Source Type: news

CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
HOUSTON, June 11, 2020 -- (Healthcare Sales & Marketing Network) -- CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and me... Biopharmaceuticals, Oncology, Neurology, FDA CNS Pharmaceuticals, Berubicin, glioma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2020 Category: Pharmaceuticals Source Type: news

Ludwig Lausanne study charts the immune landscape of multiple brain cancers
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has profiled, in a sweeping comparative analysis, the distinct immune landscapes of tumors that arise in the brain, or gliomas, and those that metastasize to the organ from the lungs, breast and skin. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 28, 2020 Category: Cancer & Oncology Source Type: news

Men and women found to have different genetic risk factors for developing brain cancer
(Natural News) Glioma, the most common type of primary brain tumor in the United States, is a malignant disease that affects mostly non-Hispanic whites. It occurs either in the brain or the spinal cord, originating in glial cells that insulate neurons and serve as their support. Depending on their rate of growth and location, gliomas can... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2020 Category: Consumer Health News Source Type: news

Brain tumors respond well to combo of radiation, schizophrenia drug
Researchers at theUCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.The findings,published May 1 in Proceedings of the National Academy of Sciences, show that a combination of radiation and the drug trifluoperazine not only targets glioblastoma cells but also helps overcome the resistance to treatment so common to this aggressive form of cancer. The results could prove promising for patients wit...
Source: UCLA Newsroom: Health Sciences - May 2, 2020 Category: Universities & Medical Training Source Type: news

Could AI Help Doctors Map Out Treatments for Brain Cancers?
FRIDAY, April 24, 2020 -- Artificial intelligence may reduce the need for glioma brain cancer patients to have biopsies to determine the best treatment for their tumors, researchers report. Currently, it's common to remove glioma samples from... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 24, 2020 Category: General Medicine Source Type: news

Study reveals how 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy
(Dana-Farber Cancer Institute) An analysis of more than 10,000 gliomas and clinical outcomes reported in Nature by scientists in Boston and Paris found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2020 Category: International Medicine & Public Health Source Type: news

Mouse study shows how advancing glioma cells scramble brain function, blood flow
(The Zuckerman Institute at Columbia University) The first sign of trouble for a patient with a growing brain tumor is often a seizure. Such seizures have long been considered a side effect of the tumor. But now a joint team of Columbia engineers and cancer researchers studying brain tumors has found evidence that the seizures caused by an enlarging tumor could spur its deadly progression. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 14, 2020 Category: Biology Source Type: news

New findings shed light on selective therapeutics for IDH1-mutated glioma
(Chinese Academy of Sciences Headquarters) Findings of a new study led by Prof. XU Guowang from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences and Prof. YANG Chunzhang from the National Cancer Institute shed light on the selective therapeutics for IDH1-mutated glioma by targeting glutathione synthesis pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2020 Category: Cancer & Oncology Source Type: news

Virginia Tech scientists reveal brain tumors impact normally helpful cells
(Virginia Tech) Unprovoked recurrent seizures are a serious problem affecting most patients who suffer from glioma, a primary brain tumor composed of malignant glial cells. Fralin Biomedical Research Institute researchers tested the hypothesis that glioma-induces processes that renders a type of brain cells dysfunctional, perpetuating the imbalance between excitation and inhibition in tumor-associated epilepsy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2020 Category: International Medicine & Public Health Source Type: news

Babies with brain tumors could benefit from targeted treatment
(Institute of Cancer Research) Brain cancer in infants is biologically distinct from other childhood brain tumors and could be successfully treated with targeted drugs, a new study has shown. In the largest and most comprehensive study of infant gliomas to date, scientists found that these tumors are molecularly different from those in older children, helping explain why they tend to be less aggressive. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2020 Category: Cancer & Oncology Source Type: news

Good news for NF patients with low grade glioma (LGG)
(Children's Tumor Foundation) A paper published in the academic journal Neuro-Oncology by NF experts has demonstrated an increased understanding of low grade gliomas (LGG) occurring in children and adults with NF1. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2020 Category: Biology Source Type: news

Combination drug therapy for childhood brain tumors shows promise in laboratory models
(Johns Hopkins Medicine) In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2020 Category: International Medicine & Public Health Source Type: news

Glioma Trials Should Track Living Well, Not Just Longer Glioma Trials Should Track Living Well, Not Just Longer
Neuro-oncology working group backs focus on how patients feel, function.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Finding a cure for Fido's brain cancer may help us find a cure for ourselves
(Jackson Laboratory) For cancers such as glioma, preclinical research models have failed to provide sufficient insight for medical progress. A team led by Jackson Laboratory's Roel Verhaak thoroughly analyzed sporadic canine gliomas and found that their molecular characteristics, including gene mutations and duplications, resemble those of humans. The results indicate that dogs provide an effective model for human gliomas, and learning how to more effectively treat our pets will likely inform better prognoses for human patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

Poliovirus therapy shows potential as cancer vaccine in lab studies
A modified form of poliovirus, pioneered at Duke Cancer Institute as a therapy for glioblastoma brain tumors, appears in laboratory studies to also have applicability for pediatric brain tumors when used as part of a cancer vaccine. In preclinical studies using mice and human cancer cells, an injection of the modified poliovirus vector instigated an immune response that homed in on mutated cancer cells that predominate in diffuse midline glioma (DMG) tumors. The cancer strikes children and is universally deadly. (Source: World Pharma News)
Source: World Pharma News - January 30, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Brain tumors remodel neuronal synapses to promote growth
(Baylor College of Medicine) Scientists discovered that glioma, a lethal form of brain cancer, alters the activity of neighboring neurons, accelerating a vicious cycle that drives tumor-associated epilepsy and tumor progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2020 Category: Cancer & Oncology Source Type: news

Study uncovers unexpected connection between gliomas, neurodegenerative diseases
(Michigan Medicine - University of Michigan) New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer's, as a biomarker for glioma development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2020 Category: Cancer & Oncology Source Type: news

Surgery May Add Years for Patients With Deadly Brain Cancer: Study
WEDNESDAY, Jan. 20, 2020 -- Surgical removal of the entire tumor may extend the lives of patients with a rare and deadly type of brain cancer called brainstem high-grade gliomas, a new study suggests. Researchers analyzed data from 103 patients in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 15, 2020 Category: General Medicine Source Type: news

Peering into the genome of brain tumor
(Osaka University) Scientists at Osaka University have created a machine learning method for classifying the mutations of glioma brain tumors based on MR images alone. Thus far, classification has only been possible by tissue sampling during surgery. The new method is noninvasive, may remove the need for a tissue sample and help accelerate delivery of treatment for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2020 Category: Cancer & Oncology Source Type: news

Connecticut boy, seven, with fatal brain tumor spends last Christmas home
Trenton O'Brien, seven, of East Haven, Connecticut, was diagnosed with a brain tumor called Diffuse Intrinsic Pontine Glioma in June 2019. He's been home, in hospice care, since Christmas Eve. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2020 Category: Consumer Health News Source Type: news

New Mom With Brain Tumor Turns To Boston Hospital For Keyhole Brain Surgery
BOSTON (CBS) — Imagine giving birth to a premature baby and then being told you have a brain tumor. That’s what happened to a woman from Holden. But thanks to a new approach at Brigham and Women’s Hospital, this new mom was able to have brain surgery and quickly return to her newborn son. At 27 weeks pregnant, Bethany Shea was diagnosed with preeclampsia and had an emergency C-section. Then she went blind. “It was a pregnancy complication due to my high blood pressure,” Bethany explained. Bethany regained her vision, but worried she had had a stroke, doctors ordered an MRI. But instead of a st...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 30, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Brigham and Women's Hospital Dr. Mallika Marshall Source Type: news

Perioperative Study of Vorasidenib Shows Promise for Patients with Low-Grade Glioma
A perioperative study confirmed brain penetrance and robust biomarker suppression in patients with low-grade glioma with an IDH1 mutation. (Source: CancerNetwork)
Source: CancerNetwork - November 27, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

NF decline but stable QOL in 1st year after temozolomide-based chemoradiotherapy
(NRG Oncology) A secondary analysis of the NRG Oncology clinical trial NRG-RTOG 0424, which initially reported a 73.1% 3-year overall survival rate, shows a decline in neurocognitive function (NCF) for half of the trial participants with high risk, low-grade gliomas (HR-LGGs) up to a year after receiving concurrent chemoradiotherapy with temozolomide. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2019 Category: Cancer & Oncology Source Type: news

Scientists drug combo that may give some hope for lethal childhood brain cancer sufferers
After using computer algorithms to sour through 9,000 possible drug combinations, Stanfors scientists found a pair with potential for treating diffuse intrinsic glioma, a rare and lethal childhood cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2019 Category: Consumer Health News Source Type: news

Scientists find promising drug combination against lethal childhood brain cancers
(NIH/National Center for Advancing Translational Sciences (NCATS)) Researchers have devised a new, promising plan of attack against deadly childhood brain cancers called diffuse midline gliomas (DMG). NCATS and Stanford University scientists and their colleagues showed that combining two drugs killed DMG patient cells grown in the laboratory and in animal models. The drugs countered the effects of a genetic mutation that causes the diseases. Their studies also uncovered an unrecognized vulnerability in the cancer cells that scientists may be able to exploit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2019 Category: International Medicine & Public Health Source Type: news

How do gliomas evolve?
(Jackson Laboratory) The Glioma Longitudinal Analysis (GLASS) Consortium characterized diffuse glioma cells both before and after therapy to characterize how they change and why this form of malignant brain cancer is so difficult to treat. The findings provide a foundation for further research and the opportunity for the clinical community to predict the effectiveness of newly developed treatments. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 20, 2019 Category: Biology Source Type: news

Pioneering blood test which uses AI to quickly scan for brain tumours is up to 90% accurate
The test, developed by University of Edinburgh, was able to identify signs gliomas, the most common form of brain tumour, with a 90 per cent success rate. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2019 Category: Consumer Health News Source Type: news

Science Saturday: Glioma Forecast? Excellent Chance for Better Weather says Researcher
Entering the Mathematical Neuro-Oncology lab on Mayo Clinic's location in Scottsdale, Arizona, is like walking onto the bridge of a ship in some fictional universe. There's a definite "Star Trek" vibe. "Yes, 'Star Trek' is good," laughs Kristin Swanson, Ph.D., a mathematical oncologist at Mayo Clinic, "but I like 'Big Bang Theory.' I kind of joke that that's [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 26, 2019 Category: Research Source Type: news

Be mindful of respiratory, motion issues with GBCAs
A comparison of two gadolinium-based contrast agents (GBCAs) for hepatobiliary...Read more on AuntMinnie.comRelated Reading: Ga-68 PSMA PET/MRI, mpMRI work for prostate cancer analysis Study shines more light on GBCA-related adverse reactions Gadolinium in gliomas, adjacent tissue raises questions German study may offer new way to detect gadolinium FDA adds 8 gadolinium MRI agents to medication guide (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 22, 2019 Category: Radiology Source Type: news

Six-year-old ’s death leads to hope of new drug for childhood cancer
Parents of Abbie Mifsud created the charity that has funded vital research on brain stem tumoursResearchers say they are close to testing a drug that could tackle a previously untreatable childhood brain cancer. The condition is known as DIPG – diffuse intrinsic pontine glioma – and every year it affects between 30 to 40 boys and girls, aged between five and 10. All develop tumours caused by the condition and die, often within months of their diagnoses.But now scientists believe they may soon be able to tackle the condition – and one of the key organisations involved is a remarkable charity set up by Aman...
Source: Guardian Unlimited Science - October 20, 2019 Category: Science Authors: Robin McKie, Observer Science Editor Tags: Drugs Health Science Society UK news Source Type: news

RT improves elderly brain cancer patient survival
A radiation therapy (RT) treatment that combines radiation with chemotherapy...Read more on AuntMinnie.comRelated Reading: Intelerad to launch enterprise software at RANZCR 2019 RANZCR issues final version of ethical AI guidelines RANZCR praises government pledge to support MRI access RANZCR proposes ethical guidelines for AI Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 18, 2019 Category: Radiology Source Type: news

RT boosts elderly brain cancer patient survival
A radiation therapy (RT) treatment that combines radiation with chemotherapy...Read more on AuntMinnie.comRelated Reading: Intelerad to launch enterprise software at RANZCR 2019 RANZCR issues final version of ethical AI guidelines RANZCR praises government pledge to support MRI access RANZCR proposes ethical guidelines for AI Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 18, 2019 Category: Radiology Source Type: news

3D VR models improve kidney-sparing surgery outcomes
Examining 3D virtual reality (VR) models during presurgical planning for robotic-assisted...Read more on AuntMinnie.comRelated Reading: AR offers 3D image guidance for interventional procedures 4 practical applications of VR, AR in radiology VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection Virtual reality, 3D printing resolve obscure lung cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2019 Category: Radiology Source Type: news

FET-PET can be useful for glioma evaluations
When glioma results are inconclusive on MRI, clinicians should consider fluoroethyl-tyrosine...Read more on AuntMinnie.comRelated Reading: How cost-effective is intraoperative MRI for gliomas? FET-PET adds 'relevant' info to pediatric cancer cases FLT-PET points toward survival for glioblastoma patients SNMMI: FET-PET could have answers for brainstem glioma SNMMI: FET-PET aids pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2019 Category: Radiology Source Type: news

Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Management to host conference call today at 8:30 a.m. Eastern SAN DIEGO, Sept. 12, 2019 -- (Healthcare Sales & Marketing Network) -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Toca 5 P... Biopharmaceuticals, Oncology Tocagen, glioma, brain cancer, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2019 Category: Pharmaceuticals Source Type: news

Blue Earth touts talks at ASTRO 2019
Bracco molecular imaging subsidiary Blue Earth Diagnostics is directing attention...Read more on AuntMinnie.comRelated Reading: Bracco to acquire Blue Earth Diagnostics Blue Earth highlights SNMMI 2019 presentations Blue Earth touts presentations at AUA 2019 Blue Earth study reports Axumin can aid glioma diagnosis Blue Earth promotes results for PET/CT agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2019 Category: Radiology Source Type: news

MS patients show signs of gadolinium retention on MRI
Seeing is believing for Italian researchers who used MRI to visually confirm...Read more on AuntMinnie.comRelated Reading: Gadolinium MRI scans most common early in pregnancy GBCA-enhanced MRI does not influence MS progression Contrast not needed for follow-up MRI on MS patients Gadolinium in gliomas, adjacent tissue raises questions German study may offer new way to detect gadolinium (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 10, 2019 Category: Radiology Source Type: news

Virtual reality relieves kids' anxiety over chest x-ray
Educating pediatric patients about their upcoming chest x-ray exam with virtual...Read more on AuntMinnie.comRelated Reading: Pediatric patients go to the dogs for MRI anxiety relief Virtual reality engages patients more than CT, booklets 4 practical applications of VR, AR in radiology VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 9, 2019 Category: Radiology Source Type: news

Structured reporting enhances brain tumor MRI
Radiologists who used structured reporting to interpret MRI scans of glioma...Read more on AuntMinnie.comRelated Reading: AI tops recent imaging informatics highlights 3 ways to reduce unnecessary MRI knee scans Structured reporting improves quality of MRI reports Structured radiology reports reduce error rate Consensus is key when developing structured report templates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 29, 2019 Category: Radiology Source Type: news

Boy, 11, diagnosed with rare inoperable brain tumor - and doctors say he has no chance of survival 
DaJuan Brown Jr, 11, of Buffalo, New York, was diagnosed in May with Diffuse Intrinsic Pontine Glioma, an inoperable brain tumor with a two-year survival rate of just 10%. (Source: the Mail online | Health)
Source: the Mail online | Health - July 9, 2019 Category: Consumer Health News Source Type: news

Bracco to acquire Blue Earth Diagnostics
Contrast developer Bracco Imaging has signed a definitive agreement to acquire...Read more on AuntMinnie.comRelated Reading: Blue Earth highlights SNMMI 2019 presentations Blue Earth touts presentations at AUA 2019 Blue Earth study reports Axumin can aid glioma diagnosis Bracco grants kids' hospital $300K for contrast ultrasound Bracco signs CT research deal with Duke Bracco's SonoVue ultrasound contrast cleared in China (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2019 Category: Radiology Source Type: news

Outcomes Poor Years After Radiation for Pediatric Glioma Survivors
Survivors treated with radiotherapy and at younger ages had poorer neuropsychological, SES outcomes (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 25, 2019 Category: Psychiatry Tags: Neurology, Pediatrics, Psychiatry, Journal, Source Type: news

Outcomes Poor Years After Radiation for Pediatric Glioma Survivors
TUESDAY, June 25, 2019 -- Survivors of childhood low-grade gliomas treated with radiotherapy have poorer neuropsychological and socioeconomic-status (SES) outcomes, according to a study published online June 24 in Cancer. M. Douglas Ris, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 25, 2019 Category: Pharmaceuticals Source Type: news